
‘Ayushman card helped my mother get timely treatment': Months after launch, how has the scheme fared in Delhi?
Since December last year, he has been complaining of severe chest pain and palpitations. A check-up revealed that two of his heart valves were not functioning. He needed heart valve replacement surgery, and his local doctor suggested he go to Delhi.
But the cost — over Rs 3 lakh — was far beyond his means. A 70-year-old farmer from Agra's Anguthi village, Prakash grew wheat on a 200-yard plot and made money based on how the crop performed.
Then came a lifeline: the announcement that the Ayushman Bharat scheme was launched in Delhi.
For Prakash, that meant access to a good private hospital, empanelled under the scheme, in the national capital — something previously out of reach.
His cousin Ram Singh, who accompanied him from the village, said that 'the surgery and hospital admission, amounting to Rs 3.5 lakh, was covered under Ayushman Bharat.
All Prakash had to pay was Rs 1,500 for the doctor's consultation fee and Rs 10,000 for diagnostic tests.
It was Prakah's doctor in Agra who suggested he get the surgery done at the Delhi hospital, which specialises in heart health. 'Doctors are not that good where we live… Delhi is close by, a four-hour road journey from the village, and doctors here are more reliable. So, we came to the city,' says Singh, adding that Prakash underwent the surgery on June 28.
Singh, also a farmer, said if not for the Ayushman card, they would have had to sell a part of their land to pay for the surgery.
On April 11, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) — the Central government's flagship health programme — was flagged off by the BJP Delhi government, promising health coverage of up to Rs 10 lakh per family per year. It was the BJP's biggest poll promise in the run-up to the Delhi Assembly elections.
Three months following its rollout, the scheme has emerged as a crucial support system for low-income families like Prakash struggling with the rising cost of private healthcare. But there are some hiccups. First, big private players are yet to come on board, citing the pricing difference. Second, officials have pointed to a lack of staff and infrastructure in hospitals for the scheme to take off.
So far, 69 private hospitals (including 7 daycare centres) and 39 central and state government hospitals (as per the PMJAY.gov.in) have been empanelled under the scheme. Among these, a majority of facilities offer Ophthalmology services, followed by General Medicine, General Surgery, Obstetrics & Gynaecology, and Orthopaedics.
Nodal officers have been appointed in these hospitals, and their numbers are provided on the website of the National Health Authority (NHA). The NHA is the apex body responsible for the scheme's implementation.
Since Delhi was onboarded onto the PMJAY, a total of 3,92,181 Ayushman cards have been issued to residents, and over 20,000 hospital admissions have taken place so far. Top procedures conducted in Delhi include chronic hemodialysis, cataract surgery, cesarean delivery, and common bile duct laparoscopic surgery.
To understand the early impact of AB-PMJAY in Delhi, The Indian Express visited 15 private hospitals empanelled under the scheme and spoke to patients and officials about the benefits and challenges.
Over the course of a week, The Indian Express found several patients from Delhi and nearby states availing of the scheme's benefits. Many also stopped by Ayushman kiosks set up at some hospitals to inquire about eligibility and services.
At one such hospital was Mahendri Devi. The 73-year-old had to undergo surgery for a broken leg — she had been hit by a bull at her home in Narela's Kheda Khurd village.
Her son, Manoj, a farmer, rushed her to a nearby private hospital and inquired whether the Ayushman card could be used. The hospital confirmed her eligibility under the scheme.
He said he had to pay Rs 15,000 for initial diagnostic tests, which were not covered, but the cost of the surgery and hospital admission was taken care of under the scheme.
'Thanks to the card, my mother received timely treatment,' he said. 'Otherwise, we would have spent lakhs.'
Devi received her Ayushman card from Delhi Chief Minister Rekha Gupta on April 28; she was among 40 elderly beneficiaries who were given the card at the launch of the Ayushman Bharat Vaya Vandana Yojana, a scheme for those aged 70 and above.
Manoj had one grouse, though — he said he was yet to receive any official confirmation detailing how much of the scheme's benefit was utilised for his mother's treatment.
At many hospitals, however, patients faced issues.
They complained that the scheme was not prominently advertised — The Indian Express also found no posters or display charts explaining its benefits. Many were also unclear about which services were actually covered.
Saaki Ram Lal from Jhansi, who recently underwent a bypass surgery at a private hospital in South Delhi, said he wasn't aware that the hospital provided coverage under Ayushman Bharat. 'There was no board or poster we could refer to. We did not inquire either,' he said.
Some patients reported information gaps. Manohar Lal (45), a prostate cancer patient, was undergoing treatment at a major cancer care hospital in West Delhi. He had been advised to undergo chemotherapy. But the hospital told him that it wasn't covered under Ayushman Bharat and would be billed for it — forcing him to stop treatment.
'I didn't know it wasn't covered. I will now go to a government hospital,' he said.
An official in the state health department said cancer care is one of the biggest challenges when it comes to coverage under Ayushman Bharat, owing to how expensive it is. 'Since investment in cancer care is very high, hospitals are not very keen to cater to such patients.'
'Chemotherapy drugs can cost anywhere between Rs 40,000 and Rs 1.50 lakh,' he added.
In a similar case, Ram Singh (73) had taken his wife, Kalawati, to a private hospital in Southeast Delhi to get her cataract treated. He was charged Rs 1,500 for an OPD consultation in the ophthalmology department — he didn't know it wasn't covered under the scheme.
'They should have told me. I had no money… My son lives in Faridabad, while we live in Sangam Vihar. We are on our own,' he said.
Singh used to work as a contractor. He gets by with occasional support from his son.
He then reached out to the area MLA, who asked him to visit the hospital again with his ration card to avail of the OPD consultation under the EWS scheme for free.
Seventy-two-year-old Ashok Pandey and his wife Sita Devi faced trouble paying for diagnostic tests at a private hospital in Central Delhi. Devi was diagnosed with a tumour in her stomach.
The couple, who lives in Karawal Nagar, said the doctor had prescribed several tests, but they were not covered by the hospital under PM-JAY. 'We'll have to spend thousands on a CT scan and biopsy… Only after these tests are done will the treatment begin,' said Ashok, a retired MCD school teacher.
At some facilities, services under PMJAY have not started due to numerous reasons.
When The Indian Express contacted hospitals listed as empanelled on the official PMJAY website, it found that:
-Registrations at several hospitals were still pending.
-Some hospitals were in the process of setting up a portal for the billing system.
-Several were hiring new staff before beginning operations under the scheme.
-A few hospitals reported issues on the 'backend' of the system.
-Many were yet to sign the memorandum of understanding.
-Some were still completing the required documentation.
An official in the state health department acknowledged the issues. He said, 'Earlier, before the scheme was implemented in Delhi, it was the National Health Authority (NHA) that oversaw hospitals treating patients from other states. After the scheme was rolled out in Delhi, hospitals had to sign a fresh MoU with the state government, which has caused delays in the start of services.'
'We are facing challenges in the empanelment process, which we are actively working to resolve. Key issues include setting up the required infrastructure in each Delhi hospital, hiring staff for the scheme, deciding their salary structures, and establishing the billing portal,' added the official.
While Delhi government hospitals will provide services free of cost, implants and consumables for patients will be covered under the scheme.
According to sources in the state health department, a major challenge is that many empanelled hospitals are dissatisfied with delayed payments, reduced incentives from the NHA, and ongoing discussions over low tariffs. 'Hospitals have raised these issues with us, and we are trying to resolve them,' the official added.
He said this is also why many big players are not on board with the scheme. 'Officials have been in constant touch with private hospitals. Even hospitals providing services in other states, but not in Delhi, have shown reservations owing to the low tariff,' the official added.
Delhi Health Minister Pankaj Singh and the Delhi Health Secretary did not respond to calls and messages seeking comment.
To be sure, when the BJP government completed 100 days in power on May 31, Singh had said that all 'big hospitals' of Delhi would be brought under the Ayushman Bharat insurance umbrella in the next '20-25 days'.
At the time, Singh had said private hospitals were hesitant to sign up because the previous AAP government did not clear pending payments under other schemes: 'They did not make the payment on time from Delhi Arogya Nidhi (the financial assistance scheme run by the Directorate General of Health Services). Now I ensure that in the next 20-25 days, all big hospitals will be empanelled under Ayushman Bharat.'
The previous AAP government had refused to implement Ayushman Bharat in Delhi on the grounds that its own schemes were better. The AAP's schemes included free treatment for all citizens in government hospitals and free surgeries in 81 private hospitals for those who had to wait a long time for diagnoses and treatment in government-run hospitals.
Dr Vipender Sabherwal, convenor for Ayushman Bharat, who is also representing the Association of Healthcare Providers India (APHI), said the association is planning to issue a white paper to the NHA on the issues being faced.
AHPI represents about 15,000 private hospitals, including Fortis, Max Healthcare, Manipal, Medanta, Narayana and Apollo.
'We will do it in the next 10 days… There has been no headway so far, because of which major private players are not on board. Even those who are providing services are not very happy and are reconsidering their decision,' he added.
Despite the issues around coverage and services, beneficiaries are happy with the scheme.
Manoj, who is the sole breadwinner of his family comprising his parents, wife, and two children, said it took a load off his chest. He earns Rs 25,000 a month growing wheat and a few vegetables in the village.
'I was relieved. Otherwise, I would have been forced to take a loan or run around to arrange money for my mother's surgery,' he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
Costly Drug Now Free For Needy Patients With Rare Skin Disease: Doctors & NGO
Nagpur: Needy patients suffering from a rare and painful skin disorder, Autoimmune Blistering Disease, can now receive the costly drug, Rituximab, free of charge, thanks to the initiative by the Pune-based foundation, AIBDF. The announcement came during a doctors' and public awareness programme organised by the Vidarbha Dermatology Society (VDS) attended by over 200 dermatologists from across Vidarbha. "This disease is rare but deadly, and incredibly painful. Our foundation provides Rituximab injection free of cost to needy patients so they can access the best treatment," said Dr Vikrant Saoji, a senior dermatologist. Suratwala explains that he started AIBDF in memory of his late wife, Jayshree Suratwala, who tragically lost her life to this disease during the pandemic. "I wanted to ensure that no one else suffers the way she did," he said. Senior dermatologist Dr Vinit Dubey from Chandrapur sent the very first patient to AIBDF in 2023. "The patient came from a very poor family," he said, adding, "Thanks to AIBDF, my patient received the expensive medicine for free and is now doing well." Dr Asra Khumushi, president of VDS, says the initiative is a game-changer for many underprivileged patients. "I have several patients with autoimmune blistering diseases, and many come from low-income backgrounds. Steroids are often prescribed but have severe side effects. Rituximab is the most proven and effective drug. Thanks to this NGO, it's possible now for many poor patients to get this treatment," Dr Khumushi explains. Dr Nitin Barde, another dermatologist, highlighted the financial relief for patients. "The entire treatment still adds up to around Rs one lakh. The foreign version costs over Rs three lakh per dose. So, getting this drug free of cost is a huge relief for patients," he says. Jayant Hemade, co-founder of AIBDF, and a family friend of Suratwala, said the NGO has far helped 25 patients. "Until now, the foundation was entirely funded by Suratwala. But we've recently secured CSR certification and will start accepting corporate support," Hemade said. He urged both patients and dermatologists to spread the good word. VDS secretary Dr Priyanka Magia discussed the importance of early diagnosis. "Hundreds of dermatologists across Vidarbha are now aware of this service. I urge anyone experiencing symptoms of this disease to consult a dermatologist as soon as possible, because patients must go through specialists to avail this benefit," Dr Magia advises. According to doctors, AIIMS Nagpur treated 70 patients with autoimmune blistering diseases in the past three years, highlighting the growing need for accessible treatment in the region. Autoimmune Blistering Diseases (AIBDs) * Rare but potentially life-threatening skin disorders * Immune system mistakenly attacks skin and mucous membranes * Causes painful blisters, sores, infections * AIIMS Nagpur treated 70 patients in just 3 years — significant for such a rare illness * Often treated with steroids, but these have serious side effects * Rituximab is the most proven and effective drug * AIBDF now provides Rituximab free of cost to needy patients * 25 patients helped so far by the foundation


India Gazette
an hour ago
- India Gazette
Himachal: AIIMS Bilaspur sets target to make state self-reliant in healthcare
Bilaspur (Himachal Pradesh) [India], July 6 (ANI): The All India Institute of Medical Science (AIIMS) Bilaspur is all set to make Himachal Pradesh a self-reliant state in health care. The AIIMS Bilaspur Director, Prof DN Sharma, shared significant milestones of the institute's progress with the media on Sunday, highlighting rapid infrastructure expansion, medical breakthroughs, and a focused drive toward cancer research and trauma care. In just less than three years since its inception, AIIMS Bilaspur has increased its inpatient capacity from 690 to 728 beds, catering to over 1,500 patients daily, with more than 4,000 indoor admissions every month. The institute also recorded its first successful kidney transplant, a major achievement in its clinical journey. Over 30,000 patients are being treated monthly, and the hospital has developed a strong community outreach programme, backed by interdisciplinary collaborations and state-of-the-art equipment, including an MRI facility. AIIMS Bilaspur is equipped with four times more ventilators than other hospitals in Himachal Pradesh, ensuring robust emergency preparedness. With a strong academic backbone, the institute now has 620 students, including 100 MBBS seats, and offers 17 broad specialities. However, Prof. Sharma noted that some faculty positions in medical gastroenterology remain vacant, though recruitment drives are ongoing. Cancer care remains a major focus area, with work underway for a dedicated Trauma Centre, and a proposal for Phase 2 expansion valued at Rs 178.05 crore. A feasibility survey for Rs 332 crore has also been conducted to support future developments, including enhanced cancer treatment infrastructure. AIIMS Bilaspur is also actively participating in ICMR-backed research projects on breast and cervical cancer and has seen high utilisation in its radiation oncology department, treating 83 patients regularly, with daily attendance ranging from 20 to 30 patients, nearing 900 total so far. Prof Sharma emphasised lifestyle-related cancers and rising cases such as lung cancer, along with Delhi topping the chart for prostate cancer prevalence. AIIMS Bilaspur is also expected to soon be equipped with PET scan and titration control facilities to enhance diagnostic precision. AIIMS Bilaspur is now among the fastest-growing AIIMS in the country, both in terms of infrastructure and services and aims to ensure that people in the region no longer need to travel outside Himachal Pradesh for advanced treatment. (ANI)


United News of India
2 hours ago
- United News of India
Dr Jitendra Singh launches National BioBank' for personalised healthcare for every Indian
New Delhi, July 6 (UNI) Union Minister of State for Science and Technology and Vice President of CSIR, Dr. Jitendra Singh, today inaugurated the Phenome India National Biobank National aiming to promise personalised healthcare for every Indian based on their genetic background, lifestyle and envirornment. Designed on the lines of the UK Biobank but contextualised for Indian diversity, the biobank will collect and analyse genetic, lifestyle and clinical data from 10,000 individuals across the country. It is housed at the Council of Scientific and Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB) here. Dr Singh who also launched India's first longitudinal population health study on the occasion, said, 'This is a decisive step towards individualised healthcare, one where treatment can be tailored to a person's genetic background, lifestyle and environment.' The Biobank will support long-term research into a host of conditions including diabetes, cardiovascular disorders, rare genetic diseases and cancers, with a view to improve diagnostics, therapeutic targeting and disease prevention strategies, said a statement from the Ministry. Highlighting the unique metabolic and epidemiological characteristics observed in the Indian population, Dr. Singh underscored the need for population-specific strategies. 'Indians may appear lean but still harbour central obesity, a known risk factor for diabetes and cardiovascular diseases,' he noted. 'Our conditions are complex and deeply heterogeneous. This is where the Biobank becomes vital.' CSIR-IGIB's current projects, including indigenous CRISPR trials for sickle cell anaemia, efforts against antimicrobial resistance (AMR), and diagnostics for liver fibrosis and rare disorders, are expected to greatly benefit from the high-resolution health data generated through the Biobank. Calling for enhanced synergy between research institutions, government departments and the private sector, Dr. Singh emphasised the need to bridge lab-based research with social impact. 'Scientific breakthroughs must transition from the bench to the bedside—and ultimately to the marketplace,' he said. Dr. N. Kalaiselvi, Director General of CSIR and Secretary, DSIR, emphasised its potential to evolve into a global benchmark. 'This is a baby step today, but it holds the promise to rival international projects in both scale and depth,' she said. Dr. Kalaiselvi also reiterated CSIR's efforts in developing affordable diagnostics and CRISPR-based therapies in collaboration with tribal communities, particularly for sickle cell anaemia—a disease with high prevalence in certain regions of India. Reflecting on IGIB's pioneering legacy in genomics, Dr. Souvik Maiti, Director of CSIR-IGIB, noted that the institute was the first in India to begin decoding the human genome, even before sequencing tools became widely available. He cited IGIB's development of over 300 genetic diagnostics, its leadership in COVID-19 genome surveillance, and India's first Drug Genome Project. IGIB's expanding research now includes women-centric studies, breast cancer genomics, and innovative work in space biology and AI-assisted pilot fitness assessments in collaboration with the Indian Air Force, said the statement. UNI AJ GNK